DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Assets
Cash & Equivalents $14.1M $2.1M $4.5M $2.2M $5.8M $2.1M $4.7M $2.8M
Accounts Receivable $391.0K $399.0K $369.0K $310.0K $188.0K $57.0K $82.0K $75.0K
Inventory — — — — — — — —
Total Current Assets $55.0M $47.5M $53.7M $47.9M $41.2M $29.7M $33.8M $36.5M
Property, Plant & Equipment $152.0K $132.0K $131.0K $135.0K $133.0K $136.0K $136.0K $110.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $56.8M $49.3M $54.2M $58.1M $62.1M $30.2M $34.4M $37.0M
Liabilities
Accounts Payable $759.0K $716.0K $926.0K $863.0K $856.0K $1.8M $734.0K $864.0K
Total Current Liabilities $3.1M $2.6M $2.8M $2.2M $1.9M $2.8M $2.2M $1.5M
Long-Term Debt — — — — — — — —
Total Liabilities $3.4M $2.9M $3.1M $2.5M $2.3M $3.2M $2.6M $2.0M
Stockholders' Equity
Retained Earnings $-125.8M $-120.7M $-115.6M $-110.4M $-105.9M $-101.4M $-96.2M $-92.4M
Total Stockholders' Equity $53.4M $46.3M $51.1M $55.6M $59.7M $27.0M $31.8M $35.1M
← Newer Page 2 of 4 Older →